148 related articles for article (PubMed ID: 22238943)
1. [Use of liquid-based endometrial cytology in breast cancer patients receiving tamoxifen].
Protasova AÉ; Raskin GA; Orlova RV; Protasov DA; Tiukavina NV
Vopr Onkol; 2011; 57(5):675-9. PubMed ID: 22238943
[TBL] [Abstract][Full Text] [Related]
2. [Expression of hormonal receptors (alpha-estrogen, beta-estrogen, progesteron), Ki-67 and P53 in endometrium of tamoxifen treated breast cancer patients].
Negoiţă M; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):834-8. PubMed ID: 22046795
[TBL] [Abstract][Full Text] [Related]
3. [Tamoxifen and endometrial pathology].
Negoiţă M; Terinte C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
[TBL] [Abstract][Full Text] [Related]
4. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
[TBL] [Abstract][Full Text] [Related]
5. A simple inexpensive screening test for endometrial abnormalities in asymptomatic women using tamoxifen.
Archer DF
Menopause; 2010; 17(3):454-5. PubMed ID: 20386342
[No Abstract] [Full Text] [Related]
6. Uterine sarcoma after tamoxifen therapy for breast cancer.
Samuji M; O'Sullivan R; Shireen R
Ir Med J; 2013 Sep; 106(8):246. PubMed ID: 24282897
[TBL] [Abstract][Full Text] [Related]
7. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR;
Hum Reprod; 2005 Jan; 20(1):294-301. PubMed ID: 15513977
[TBL] [Abstract][Full Text] [Related]
8. Value of the progesterone test in screening for endometrial pathology in asymptomatic postmenopausal women receiving treatment with tamoxifen.
Lubian López DM; Fernandez YG; Rodríguez BR; López FM; Delgado RC
Menopause; 2010; 17(3):487-93. PubMed ID: 20464783
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of endometrial pathologies, especially for endometrial cancer, of breast cancer patients under tamoxifen treatment.
Neri F; Maggino T
Eur J Gynaecol Oncol; 2009; 30(4):357-60. PubMed ID: 19761121
[TBL] [Abstract][Full Text] [Related]
10. Effect of tamoxifen on endometrial histology, hormone receptors, and cervical cytology: a prospective study with follow-up.
Leslie KK; Walter SA; Torkko K; Stephens JK; Thompson C; Singh M
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):284-93. PubMed ID: 17721273
[TBL] [Abstract][Full Text] [Related]
11. Müllerian adenosarcoma of the uterus with sarcomatous overgrowth following tamoxifen treatment for breast cancer.
Carvalho FM; Carvalho JP; Motta EV; Souen J
Rev Hosp Clin Fac Med Sao Paulo; 2000; 55(1):17-20. PubMed ID: 10881074
[TBL] [Abstract][Full Text] [Related]
12. [Tamoxifen, endometrial cancer risk and liquid based cytology. A paradigmatic case].
Fambrini M; Buccoliero AM; Pieralli A; Andersson KL; Mattei A; Scarselli G; Taddei G; Marchionni M
Minerva Ginecol; 2011 Oct; 63(5):465-70. PubMed ID: 21926955
[TBL] [Abstract][Full Text] [Related]
13. Myxoid leiomyosarcoma of the uterus in a patient receiving tamoxifen therapy: a case report.
Botsis D; Koliopoulos C; Kondi-Pafitis A; Creatsas G
Int J Gynecol Pathol; 2006 Apr; 25(2):173-5. PubMed ID: 16633068
[TBL] [Abstract][Full Text] [Related]
14. [Some specifics of tamoxifen's effect on the endometrium in menopausal cancer patients].
Ashtrafian LA; Antonova IB; Chazova NL; Motskobili TA; Babaeva NA; Al'ditskiĭ IA
Vopr Onkol; 2005; 51(2):200-5. PubMed ID: 16223001
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of the endometrial pathology using flexible ambulatory hysteroscopy of patients treated with Tamoxifen].
Kuzmanov B
Akush Ginekol (Sofiia); 2004; 43(3):32-3. PubMed ID: 15341254
[TBL] [Abstract][Full Text] [Related]
17. Surveillance for endometrial cancer in women on tamoxifen: the role of liquid-based endometrial cytology - cytohistological correlation in a population of 168 women.
Buccoliero AM; Fambrini M; Gheri CF; Castiglione F; Garbini F; Barbetti A; Rossi Degl'Innocenti D; Moncini D; Taddei A; Bargelli G; Scarselli G; Marchionni M; Taddei GL
Gynecol Obstet Invest; 2008; 65(4):240-6. PubMed ID: 18196906
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
19. [Endometrial ablation versus hysterectomy in women treated with tamoxifen].
Capuano I; Caporale A; Vagnetti P; Di Domenico A; Felicetti M; Torella M; Borrelli AL
Minerva Ginecol; 2007 Oct; 59(5):499-504. PubMed ID: 17912176
[TBL] [Abstract][Full Text] [Related]
20. Molecular markers in the endometrium at baseline of postmenopausal patients with early breast cancer in the ATAC (Arimidex, tamoxifen, alone, or in combination) trial.
Duffy SR; Taylor L
Am J Obstet Gynecol; 2004 Dec; 191(6):1921-7. PubMed ID: 15592273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
